Navigation Links
Derma Sciences Obtains Exclusive Worldwide Rights to MEDIHONEY(R)
Date:12/22/2009

PRINCETON, N.J., Dec. 22 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a specialty medical device and pharmaceutical company focused on advanced wound care, today announced that it has completed a comprehensive Heads of Agreement with Comvita New Zealand Ltd. (Comvita) of Paengaroa, New Zealand, covering the worldwide licensing rights for MEDIHONEY® professional wound care and skin care products.

The agreement effectively triples the potential market for Derma Sciences' MEDIHONEY® products. The company currently has North & South America rights only, representing about one-third of the total market, and the agreement would give Derma Sciences rights to the remaining 67%. Comvita controls approximately 75% of worldwide Leptospermum (manuka) honey production and are the owner of key intellectual property and patents concerning the use of honey in medical dressings.

The Heads of Agreement calls for the following:

  1. Derma Sciences to have exclusive worldwide rights to manufacture and sell the full range of MEDIHONEY® wound care and skin care products to the professional and medical market worldwide.
  2. Derma Sciences to manufacture the range of MEDIHONEY® products for Comvita to sell to OTC customers.
  3. Comvita to supply medical-grade manuka honey to Derma Sciences.
  4. Derma Sciences to have all IP rights to MEDIHONEY®, including patents involving dressings composed of more than 50% manuka honey.
  5. A joint Research & Development cooperation agreement between Derma Sciences and Comvita.

The agreement also states that Comvita CEO Brett Hewlett will join Derma Science's Board of Directors.


'/>"/>
SOURCE Derma Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix
2. Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds
3. Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis
4. Derma Sciences Files S-1 Registration Statement
5. Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call
6. Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R)
7. Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD
8. Derma Sciences Announces Multiple Clinical Presentations of MEDIHONEY(R) at Upcoming Major Wound Care Conference
9. Estrogen Getting Cool Reception From Dermatologists for Mixed Results in Improving Appearance of Skin
10. Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
11. BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)...  B. Braun Medical Inc. (B.Braun) is committed ... products, services and education focused on sharing best ... 400ES and Space Infusion Systems, and unique DoseTrac® ... Association of Critical-Care Nurses (AACN) National Teaching Institute, ... Convention Center. Clinical Experts ...
(Date:5/20/2013)... 20, 2013 Landauer, Inc. (NYSE: ... radiation measurement and monitoring, outsourced medical physics services and ... Board of Directors declared, at its meeting on May ... per share for the third quarter of fiscal 2013.  ... to shareholders of record on June 7, 2013. ...
(Date:5/20/2013)...  Uroplasty, Inc. (Nasdaq: UPI ) announced ... fiscal fourth quarter and full year ended March 31, ... 2013. The Company will host a conference call and ... 2013 at 4:30 p.m. Eastern Time (3:30 p.m. Central ... should dial 888-549-7750, no passcode is necessary. To access ...
Breaking Medicine Technology:B. Braun Committed To Improving Patient Safety 2Landauer, Inc. Declares Regular Cash Dividend 2Uroplasty To Announce Fiscal Fourth Quarter And Full Year 2013 Financial Results On May 30, 2013 2
... 26, 2007 - Aeolus,Pharmaceuticals, Inc. (OTCBB:AOLS) announced ... issue of the Journal of Neuroscience a ... and National Jewish,Medical and Research Center demonstrating ... AEOL 11207, demonstrated,neuroprotection in an animal model ...
... adding Diovan to conventional therapy , , , Study ... , , BASEL,Switzerland, April 27, 2007 ... published today in The Lancet[1], show that,adding the blood ... 39% reduction in,cardiovascular events and a 40% reduction in ...
Cached Medicine Technology:Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 2Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 4Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 5Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 6Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 7
(Date:5/20/2013)... FL (PRWEB) May 20, 2013 Leading facial ... to be recognized as a “Top Doc” in the field ... Beacher Magazine. , The Palm Beacher magazine, one of ... of “Top Docs” in the May/June 2013 issue, including 70 ... best restaurants and dining, events, things to do, health and ...
(Date:5/20/2013)... According to a May 6, 2013 CBS News ... tanning salons in the US may soon have ... wants to see cancer warnings on indoor tanning beds ... eighteen for the use of indoor tanning and sun beds. ... become increasingly common over the last few decades (Go to ...
(Date:5/20/2013)... May 20, 2013 Mirena IUD ... the multidistrict litigation recently established in U.S. District Court, ... According to court records, the litigation’s first Status ... appointments to Plaintiff’s leadership positions were discussed. So ... the Southern District of New York, all of which ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 ... Foundation will be holding a ... Lansing on June 10th. , ... 10th, 6:30 p.m. – 8 ... (Across from Sparrow Hospital),                  ...
(Date:5/20/2013)... 20, 2013 The Environmental ... feature dozens of continuing education credit opportunities for ... Institute of Architects Continuing Education System (AIA/CES), the ... the Interior Design Continuing Education Council (IDCEC). ... 1, 2013 at the Omni Providence Hotel in ...
Breaking Medicine News(10 mins):Health News:Dr. Schwartz Named “Top Doc” by The Palm Beacher Magazine 2Health News:Tanning - FDA Wants Tanning Salons to Post Cancer Warning Signs 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 3Health News:Environmental Design Research Conference to Feature AIA/CES, LA CES, and IDCEC Continuing Education Credits 2
... by ticks , THURSDAY, Oct. 4 (HealthDay News) -- Many ... may actually have been bitten by another tick and have ... "It is striking how often re-infection appears to occur," lead ... York Medical College, said in a prepared statement. "Our findings ...
... Institute of Child Health and Human Development (NICHD) announced ... was awarded a competitive contract to participate in the ... be conducted in the United States to assess the ... human health. The study will follow 100,000 children from ...
... A 1998 settlement designed to limit the marketing of smokeless ... University of Georgia study published in the early online edition ... rates are significant and have been very stable over the ... the UGA Grady College of Journalism and Mass Communication. We ...
... Oct. 4 Nastech Pharmaceutical,Company Inc. (Nasdaq: ... "Rick",Costantino, Ph.D., to Chief Scientific Officer of Delivery. ... development of new,drug delivery technologies for peptide and ... since 2003, is retiring,tomorrow, October 5, 2007, as ...
... Energizer has forged a,national partnership with Susan ... its,encouraging message-the Power to Keep Going(R)-to more than ... (Photo: http://www.newscom.com/cgi-bin/prnh/20071004/AQTH013 ) Officials with ... a,special one. Energizer is the battery known around ...
... which a cell protein protects cancer cells,from a ... target for,improving treatment outcomes for patients., A team ... Medical Research (CCIA), led,by Associate Professor Maria Kavallaris, ... could play an important role in resistance to ...
Cached Medicine News:Health News:Lyme Disease Relapse Often a New Infection 2Health News:UMASS Medical School awarded National Children's Study contract 2Health News:UMASS Medical School awarded National Children's Study contract 3Health News:UMASS Medical School awarded National Children's Study contract 4Health News:UGA study: Youth exposed to smokeless tobacco ads despite settlement 2Health News:UGA study: Youth exposed to smokeless tobacco ads despite settlement 3Health News:Nastech Pharmaceutical Company Announces Promotion of Rick Costantino, Ph.D., to Chief Scientific Officer of Delivery 2Health News:Nastech Pharmaceutical Company Announces Promotion of Rick Costantino, Ph.D., to Chief Scientific Officer of Delivery 3Health News:Energizer Joins Roster of Susan G. Komen Race for the Cure(R) National Sponsors; Energizer(R) ReTreat Pampers Cancer Survivors With Traveling Mini-Spa 2Health News:Energizer Joins Roster of Susan G. Komen Race for the Cure(R) National Sponsors; Energizer(R) ReTreat Pampers Cancer Survivors With Traveling Mini-Spa 3Health News:Cell skeleton may hold key to overcoming drug resistance in cancer 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: